Business

AstraZeneca likely won't be first coronavirus vaccine to market but could be most widely available

Drugmaker AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.
Details
Transcript

Drugmaker AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.

Reporter : Joe Fisher
Photographer : Richard Adkins
Web Editor : Matthew Burns
Posted 2020-11-23T20:07:29-0500 - Updated 2020-11-23T20:10:06-0500